Cocrystal Pharma (NASDAQ:COCP) reported quarterly losses of $(0.25) per share. This is a 525 percent decrease over losses of $(0.04) per share from the same period last year.
Tesla’s NACS Charging Revolution Explained: Who’s In And Who’s Out So Far
In recent years, the electric vehicle industry has witnessed a significant shift in charging standards, particularly in North…